Back to Franklin Templeton Inc. Franklin Templeton Inc.

FATEFATE

Showing 5 of 24 quarters

Position history for Franklin Templeton Inc.Franklin Templeton Inc.'s holdings in Fate Therapeutics, Inc.

No. Franklin Templeton exited its FATE (Fate Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 10,197 shares worth $11,421. Franklin Templeton already held FATE in its Q3 2019 13F, the earliest on record, and held it in 22 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$460,003

Total Shares Change

-150,821

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$1.26
0
2025-Q2
Unchanged
10,197
0.0%
$11,4210.0%$1.12
0
2025-Q1
Decreased
10,197
-93.8%
$8,0570.0%$0.79
0
2024-Q4
Increased
165,353
+9.6%
$272,8330.0%$1.65
26
2024-Q3
Decreased
150,821
-34.4%
$460,0030.0%$3.50
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used